VOLEKAM (Volecamum).

     Solution 6% oksietilkrahmala with molecular weight 170000 + 30000 in isotonic sodium chloride solution.

     Transparent colourless liquid; PH 5, 0, 7, 0.

     Volekam is kolloidoosmoticheskim plazmozameschayuschim drug hemodynamic action. Effective with the state involving gipovolemicheskim syndrome (with traumatic shock, burns, krovopoteryah etc.).

     Enter volekam struyno drip through the filter for blood transfusions. Given the sensitivity of the individual patient to the various transmission media, are beginning to drip infusion. Since the introduction of the first 5 - 10 and the next 30 drops, it is necessary to take a break for 3 minutes to determine patient tolerance of the drug.

     In razvivshemsya shock, accompanying krovopoterey, volekam struyno injected dose of 500 ml.

     If necessary dose of the drug could be increased to 1500 ml.

     Using volekama not preclude the need for other activities protivoshokovyh (pain and the use of heart, and other symptomatic vazotonicheskih funds).

     In operations to prevent operatsinnogo shock volekama intravenous dose of 400-600 ml should drip with the changeover to the desk in the event of the fall in blood pressure.

     In aftercare period volekam impose struyno drip krovopotere respectively.

     The total dose volekama in pre and aftercare periods determined hemodynamic performance and condition of patients at 1500 ml / day.

     The drug can be used in conjunction with other traditional means of transmission (poliglyukin, gemodez etc.).

     In applying volekama possible allergic reactions (urtikarnye nausea, skin itch, swelling Kvinke etc.), increased heart rate, decrease blood pressure, increased body temperature, headache, nausea, vomiting. In these cases, volekama infusion should be discontinued and a symptomatic treatment.

     Application volekama contraindicated in skull trauma, accompanied by rising vnutricherepnogo pressure, and other times not receive intravenous fluids in a high doses, especially in high-AD, heart failure stagnant nature, kidney function violations involving oligo- or anuriey.

     Product : in glass bottles for 100; 200, and 400 ml.

     Storage : at a temperature of + 10  to  + 25'C. Freezing is not allowed.

Materials allowed to copy only with the active hyperlink to the handbook of medicines